Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CMMB

Chemomab Therapeutics (CMMB)

Chemomab Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMMB
DateTimeSourceHeadlineSymbolCompany
06/21/20227:00AMPR Newswire (US)Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of DirectorsNASDAQ:CMMBChemomab Therapeutics Ltd
06/09/20229:00AMPR Newswire (US)Chemomab Therapeutics to Present at June Investor and Scientific ConferencesNASDAQ:CMMBChemomab Therapeutics Ltd
06/08/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
06/02/20227:00AMPR Newswire (US)Data Supporting Role of Chemomab's Novel Therapeutic Target CCL24 in Systemic Sclerosis Presented at EULAR 2022NASDAQ:CMMBChemomab Therapeutics Ltd
05/31/202210:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CMMBChemomab Therapeutics Ltd
05/25/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
05/19/20224:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
05/18/20227:00AMPR Newswire (US)Chemomab Therapeutics to Participate in H.C. Wainwright Global Investment ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
05/12/20226:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
05/12/20226:00AMPR Newswire (US)Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
05/04/20227:00AMPR Newswire (US)Chemomab Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
04/28/20224:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CMMBChemomab Therapeutics Ltd
04/25/20224:20PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CMMBChemomab Therapeutics Ltd
03/23/20227:00AMPR Newswire (US)Chemomab Therapeutics to Participate in Cantor Fitzgerald Rare Orphan Disease SummitNASDAQ:CMMBChemomab Therapeutics Ltd
03/15/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/15/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/14/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/14/20228:00AMPR Newswire (US)Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic SclerosisNASDAQ:CMMBChemomab Therapeutics Ltd
03/09/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/09/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/09/20224:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMMBChemomab Therapeutics Ltd
03/09/20226:00AMPR Newswire (US)Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
03/02/20228:00AMPR Newswire (US)Chemomab Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Business UpdateNASDAQ:CMMBChemomab Therapeutics Ltd
02/11/20226:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
02/10/20228:00AMPR Newswire (US)Chemomab Therapeutics to Present at Aegis Virtual ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
01/04/20227:00AMPR Newswire (US)Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development OperationsNASDAQ:CMMBChemomab Therapeutics Ltd
12/20/20218:00AMPR Newswire (US)Chemomab to Participate in LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare ConferenceNASDAQ:CMMBChemomab Therapeutics Ltd
12/16/20214:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
12/16/20214:05PMPR Newswire (US)Chemomab Therapeutics Announces Expected Appointment of Dale R. Pfost as Chairman of the BoardNASDAQ:CMMBChemomab Therapeutics Ltd
12/03/20218:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMMBChemomab Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:CMMB